← All trials
NCT00512577
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2007
- Primary completion
- Mar 31, 2011
- Completion date
- Mar 31, 2011
- First posted
- Aug 7, 2007
- Last posted
- Mar 23, 2023
- Enrollment
- 70
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- NHS Blood and TransplantLead sponsor
- Medical Research CouncilCollaborator
- University of YorkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.